Gilead’s layoffs include 72 employees at its Seattle location, which will close. Kite will shut down its Philadelphia facility. The layoffs are attributed to aligning resources with long-term strategic goals.

Biopharma giant Gilead Sciences will shut down its office in Seattle's Eastlake neighborhood, the company confirmed to GeekWire on Wednesday.

Gilead Sciences, a biopharma giant known for developing COVID-19 and HIV/AIDS treatments, is closing its Seattle office, according to a state filing on Wednesday. The Washington State Employment Security Department said in the filing that 72 employees will be laid off on Jan.

The company’s website says that the Seattle office, located at 199 E. Blaine St. in Eastlake, focuses on research and clinical development activities. “We are closing our Seattle office as part of our efforts to align resources with our long-term strategic goals,